This study fits in a series of works to elucidate the mechanisms of the beneficial actions of IGF-I therapy in liver cirrhosis [13,14,39,50-57], a condition of IGF-I deficiency [11,12]. Here, IGF1 is linked to hyperinsulinemic hypoglycemia, familial, 4.